Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

586 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mutations in ompK36 differentially impact in vitro synergy of meropenem/vaborbactam and ceftazidime/avibactam in combination with other antibiotics against KPC-producing Klebsiella pneumoniae.
Rogers TM, Kline EG, Griffith MP, Jones CE, Rubio AM, Squires KM, Shields RK. Rogers TM, et al. Among authors: jones ce. JAC Antimicrob Resist. 2023 Oct 26;5(5):dlad113. doi: 10.1093/jacamr/dlad113. eCollection 2023 Oct. JAC Antimicrob Resist. 2023. PMID: 37901589 Free PMC article.
In Vitro Susceptibility of Multidrug-Resistant Pseudomonas aeruginosa following Treatment-Emergent Resistance to Ceftolozane-Tazobactam.
Rubio AM, Kline EG, Jones CE, Chen L, Kreiswirth BN, Nguyen MH, Clancy CJ, Cooper VS, Haidar G, Van Tyne D, Shields RK. Rubio AM, et al. Among authors: jones ce. Antimicrob Agents Chemother. 2021 May 18;65(6):e00084-21. doi: 10.1128/AAC.00084-21. Print 2021 May 18. Antimicrob Agents Chemother. 2021. PMID: 33820773 Free PMC article.
Impact of ompk36 genotype and KPC subtype on the in vitro activity of ceftazidime/avibactam, imipenem/relebactam and meropenem/vaborbactam against KPC-producing K. pneumoniae clinical isolates.
Rogers TM, Kline EG, Griffith MP, Jones CE, Rubio AM, Squires KM, Shields RK. Rogers TM, et al. Among authors: jones ce. JAC Antimicrob Resist. 2023 Mar 23;5(2):dlad022. doi: 10.1093/jacamr/dlad022. eCollection 2023 Apr. JAC Antimicrob Resist. 2023. PMID: 36968951 Free PMC article.
In vitro activity of clindamycin, doxycycline, and trimethoprim/sulfamethoxazole against clinical isolates of β-hemolytic Streptococcus spp. via BD Phoenix and broth microdilution.
Cho C, Shields RK, Kline EG, Walsh TL, Jones CE, Kasarda K, Stefano K, Moffa MA, Bremmer DN. Cho C, et al. Among authors: jones ce. Antimicrob Steward Healthc Epidemiol. 2023 Dec 15;3(1):e238. doi: 10.1017/ash.2023.515. eCollection 2023. Antimicrob Steward Healthc Epidemiol. 2023. PMID: 38156228 Free PMC article.
Differential in vitro susceptibility to ampicillin/ceftriaxone combination therapy among Enterococcus faecalis infective endocarditis clinical isolates.
Westbrook KJ, Chilambi GS, Stellfox ME, Nordstrom HR, Li Y, Iovleva A, Shah NH, Jones CE, Kline EG, Squires KM, Miller WR, Tran TT, Arias CA, Doi Y, Shields RK, Van Tyne D. Westbrook KJ, et al. Among authors: jones ce. J Antimicrob Chemother. 2024 Apr 2;79(4):801-809. doi: 10.1093/jac/dkae032. J Antimicrob Chemother. 2024. PMID: 38334390
Risk of Invasive Meningococcal Disease in Preterm Infants.
Calvert A, Campbell H, Heath PT, Jones CE, Le Doare K, Mensah A, Ladhani S. Calvert A, et al. Among authors: jones ce. Open Forum Infect Dis. 2024 Apr 15;11(4):ofae164. doi: 10.1093/ofid/ofae164. eCollection 2024 Apr. Open Forum Infect Dis. 2024. PMID: 38665170 Free PMC article.
Consensus recommendation for prenatal, neonatal and postnatal management of congenital cytomegalovirus infection from the European congenital infection initiative (ECCI).
Leruez-Ville M, Chatzakis C, Lilleri D, Blazquez-Gamero D, Alarcon A, Bourgon N, Foulon I, Fourgeaud J, Gonce A, Jones CE, Klapper P, Krom A, Lazzarotto T, Lyall H, Paixao P, Papaevangelou V, Puchhammer E, Sourvinos G, Vallely P, Ville Y, Vossen A. Leruez-Ville M, et al. Among authors: jones ce. Lancet Reg Health Eur. 2024 Apr 1;40:100892. doi: 10.1016/j.lanepe.2024.100892. eCollection 2024 May. Lancet Reg Health Eur. 2024. PMID: 38590940 Free PMC article. Review.
586 results